Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-YL)-isoi ndolines and their use to reduce TNFalpha levels

Details for Australian Patent Application No. 2005239663 (hide)

International Classifications

Event Publications

15 December 2005 Complete Application Filed

22 December 2005 Application Open to Public Inspection

Published as AU-B-2005239663

1 November 2007 Application Accepted

Published as AU-B-2005239663

28 February 2008 Standard Patent Sealed

9 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.